Product
WP1122
1 clinical trial
1 indication
Indication
Healthy VolunteerClinical trial
A Phase 1a, First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Overlapping Single and Multiple Ascending Dose Escalation Study of WP1122 to Establish Maximum Tolerated Dose and Evaluate PharmacokineticsStatus: Completed, Estimated PCD: 2022-10-24